Helix Biopharma Corp. - Профиль
Helix BioPharma Corp. is an immuno-oncology company, which develops products for the treatment and prevention of cancer. It focuses on the medicines in the field of immuno-oncology based on its proprietary technological platform DOS47 and Tumor Defence Attackers CAR-T. The company was founded on July 31, 1995 and is headquartered in Richmond Hill, Canada.
|CAIAC Fund Management AG||19,83|
|Slawomir Majewski, MD, PhD||1,26|